4 terminated. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 4 |
| Phase 2 | 1 | Terminated 1 |
Follow Eczema: new trials by email Literature Review of Eczema trials Research Report on Eczema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical ENS-002 for Atopic Dermatitis in Adults ENS-002 - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 1 | Terminated | Concerto Biosciences | 9 | 2024-09-18 | 2025-08-14 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD) Placebo, IMG-007 - Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis | Phase 1 / Phase 2 | Terminated | Inmagene LLC | 13 | 2023-08-09 | 2025-11-06 |
| Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis XmAb27564, Placebo - Psoriasis, Atopic Dermatitis | Phase 1 | Terminated | Xencor, Inc. | 23 | 2022-10-10 | 2025-12-02 |
| A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis Anakinra - Anakinra, Kineret | Phase 1 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 1 | 2010-04-14 | 2019-12-17 |
Dermatitis, Atopic (4) · Dermatitis (2) · Immune System Diseases (1) · Psoriasis (1) · Skin Diseases (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Genetic Diseases, Inborn (4) · Hypersensitivity (4) · Hypersensitivity, Immediate (4) · Skin Diseases, Eczematous (4) · Skin Diseases, Genetic (4) · Skin and Connective Tissue Diseases (4) · Immune System Diseases (3) · Skin Diseases (3) · Dermatitis (2) · Skin Diseases, Papulosquamous (1)
Interleukin 1 Receptor Antagonist Protein (1)
Concerto Biosciences (1) · Inmagene LLC (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Xencor, Inc. (1)
United States (4) · Canada (2)
Bernardo Cervantes, PhD (1) · Joshua D Milner, M.D. (1) · Ralph Zitnik, MD (1)